What question did this study set out to answer?

The aim is to summarize recent knowledge about cholangiocarcinoma, including its classification and therapeutic approaches.

Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

View Full Paper

Ask AI

Bookmark

The aim is to summarize recent knowledge about cholangiocarcinoma, including its classification and therapeutic approaches.
Consensus statement developed by the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Detailed classification, pathophysiology, risk factors, and current therapies documented
Future research directions in basic and clinical investigations outlined
Cholangiocarcinoma is increasingly prevalent and is the second most common primary liver tumor worldwide.
High mortality rates attributed to late diagnosis and the aggressive nature of the disease.
Consensus highlights the need for enhanced international research collaboration.

No takes yet. Share an insight, caveat, or question.

Consensus statement details classification, mechanisms, therapies for cholangiocarcinoma, indicating future research directions.

Bañales et al. (2016) studied this question.

View Full Paper

Ask AI

Bookmark